World's Best Scientists 2026 revealed!
Gavin J. Churchyard

Gavin J. Churchyard

Award Badge
Microbiology
South Africa
2026

D-Index & Metrics

Microbiology

D-Index
71
Citations
18704
World Ranking
1840
National Ranking
8

Medicine

D-Index
82
Citations
24339
World Ranking
16130
National Ranking
36

Gavin J. Churchyard publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Gavin J. Churchyard sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 259 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Gavin J. Churchyard D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Gavin J. Churchyard sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 71 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Microbiology in South Africa Leader Award

Overview

Gavin J. Churchyard is affiliated with the Aurum Institute in South Africa and has a significant body of work in the field of Medicine, with a focus on Infectious Diseases. Their research spans multiple subfields, including Epidemiology, Surgery, Immunology, and Virology.

The primary topics covered in their research include:

  • Tuberculosis Research and Epidemiology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Mycobacterium research and diagnosis
  • Diagnosis and treatment of tuberculosis
  • Pneumonia and Respiratory Infections
  • HIV Research and Treatment
  • Infectious Diseases and Tuberculosis

Churchyard has authored numerous papers, with notable recent publications including:

  • "Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial," 2021, The Lancet Infectious Diseases
  • "Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise," 2024, The Lancet Respiratory Medicine
  • "Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial," 2021, The Lancet Respiratory Medicine
  • "Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis," 2023, The Lancet
  • "Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial," 2020, The Lancet HIV

The frequent coauthors who have collaborated with Churchyard include:

  • Mark Hatherill
  • Salome Charalambous
  • Robert S. Wallis
  • Thomas J. Scriba
  • Andrew Fiore-Gartland

The most common publication venues for their research are:

  • PLoS ONE
  • The Lancet Respiratory Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The International Journal of Tuberculosis and Lung Disease
  • Journal of the International AIDS Society

Best Publications

  • The diarylquinoline TMC207 for multidrug-resistant tuberculosis

    Andreas H Diacon;Alexander Pym;Martin Grobusch;Ramonde Patientia

  • The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study

    Wouter Hoefsloot;Jakko Van Ingen;Claire Andrejak;Kristian Ängeby

  • The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

    Keertan Dheda;Tawanda Gumbo;Gary Maartens;Kelly E. Dooley

  • HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.

    Salim Safurdeen. Abdool Karim;Salim Safurdeen. Abdool Karim;Gavin J. Churchyard;Quarraisha. Abdool Karim;Quarraisha. Abdool Karim;Stephen D. Lawn

  • Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment.

    Elizabeth L Corbett;Elizabeth L Corbett;Barbara Marston;Gavin J Churchyard;Kevin M De Cock;Kevin M De Cock

  • High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

    Amina Jindani;Thomas S. Harrison;Andrew J. Nunn;Patrick P.J. Phillips

  • Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies.

    Haileyesus Getahun;Wanitchaya Kittikraisak;Charles M. Heilig;Elizabeth L. Corbett

  • Achieving the health Millennium Development Goals for South Africa: challenges and priorities

    Mickey. Chopra;Mickey. Chopra;Joy E. Lawn;Joy E. Lawn;David. Sanders;Peter. Barron

  • Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

    Glenda E. Gray;Mary. Allen;Zoe. Moodie;Gavin J. Churchyard

  • High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

    Martin J Boeree;Norbert Heinrich;Rob Aarnoutse;Andreas H Diacon

  • Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment

    Eva Hnizdo;Tanusha Singh;Gavin Churchyard

  • What We Know About Tuberculosis Transmission: An Overview.

    Gavin Churchyard;Peter Kim;N Sarita Shah;Roxana Rustomjee

  • Building a tuberculosis-free world: The Lancet Commission on tuberculosis

    Michael J A Reid;Nimalan Arinaminpathy;Amy Bloom;Barry R Bloom

  • Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection

    Jason D. Simmons;Catherine Marie Stein;Chetan Seshadri;Monica Campo

  • Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial

    Elizabeth L Corbett;Tsitsi Bandason;Trinh Duong;Ethel Dauya

  • Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers

    Robert S Wallis;Markus Maeurer;Peter Mwaba;Jeremiah Chakaya

  • Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa.

    Paul Mee;Katherine L Fielding;Salome Charalambous;Gavin J Churchyard

  • A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control

    Gavin J. Churchyard;Gavin J. Churchyard;Katherine L. Fielding;James J. Lewis;Leonie Coetzee

  • Human Immunodeficiency Virus and the Prevalence of Undiagnosed Tuberculosis in African Gold Miners

    Elizabeth L. Corbett;Salome Charalambous;Vicky M. Moloi;Katherine Fielding

  • Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF

    Gavin J Churchyard;Gavin J Churchyard;Wendy S Stevens;Wendy S Stevens;Lerole D Mametja;Kerrigan M McCarthy

  • HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners.

    Elizabeth L. Corbett;Gavin J. Churchyard;Tim C. Clayton;Brian G. Williams

Frequent Co-Authors

Katherine Fielding
Katherine Fielding University of London
Elizabeth L. Corbett
Elizabeth L. Corbett London School of Hygiene & Tropical Medicine
Richard E. Chaisson
Richard E. Chaisson Johns Hopkins University
Richard J. Hayes
Richard J. Hayes London School of Hygiene & Tropical Medicine
Linda-Gail Bekker
Linda-Gail Bekker University of Cape Town
Anna Vassall
Anna Vassall London School of Hygiene & Tropical Medicine
Koleka Mlisana
Koleka Mlisana National Health Laboratory Service
Kevin M. De Cock
Kevin M. De Cock Centers for Disease Control and Prevention
Glenda Gray
Glenda Gray South African Medical Research Council
James G. Kublin
James G. Kublin Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Microbiology who want to expand their career options, pursuing certifications and degree programs in health information and medical coding can be valuable. Becoming a certified professional coder certification is one pathway that offers specialized skills in coding medical records, which supports clinical research and healthcare documentation.

Additionally, a bachelor of science in health information management salary reflects the growing demand for professionals who can manage patient data, an area increasingly intertwined with microbiological research data management.

Students aiming to enter this field can find reputable options through online health information management degree programs cahiim accredited, ensuring quality education that meets industry standards while providing flexibility.

For quicker entry into the workforce, medical billing and coding certificate online accelerated programs offer fast-paced learning to gain essential skills in healthcare administration, complementing a background in microbiology.

Best Scientists Citing Gavin J. Churchyard

Trending Scientists

Recently Published Articles